Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: Early metabolic response without inhibition of tumor growth
Leo G. Flores, Hsin Hsien Yeh, Suren Soghomonyan, Daniel Young, James Bankson, Qianghua Hu, Mian Alauddin, Vicki Huff, Juri G. Gelovani
Dive into the research topics of 'Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: Early metabolic response without inhibition of tumor growth'. Together they form a unique fingerprint.